Home » Topics » Regulatory

Regulatory
RSS

Aradigm completes phase II trial with AERx delivery of dornase alfa for CF patients

Oct. 18, 2000

Extended-release Lescol XL cleared by FDA for cholesterol reduction

Oct. 17, 2000

FDA approves Novantrone for worsening forms of multiple sclerosis

Oct. 17, 2000

SangStat obtains technology to develop smaller ciclosporin capsule

Oct. 16, 2000

Remicade recommended for expanded approval in Europe

Oct. 13, 2000

Shire submits NDA for once-daily Adderall for ADHD

Oct. 13, 2000

FDA approves first and only once-monthly contraceptive for women

Oct. 10, 2000

Ciba Vision and QLT seek to expand Visudyne indication in the E.U.

Oct. 5, 2000

First prescription drug to treat unwanted facial hair introduced in U.S.

Oct. 5, 2000

FDA approves breath-activated device with corticosteroid for asthma

Oct. 5, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 13, 2025.
Bayer secures KRAS G12D inhibitor with $1.3B Kumquat deal
BioWorld
With a packed pipeline of drug candidates targeting multiple markers of cancer, Bayer AG signed on for a new project, this time going after the KRAS pathway with...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for August 13, 2025.
Scemblix ticks Novartis earnings box; more ahead in CML
BioWorld
Novartis AG’s financial update included good news about Scemblix (asciminib), the first and only U.S. FDA-approved allosteric inhibitor for chronic myeloid...
FDA warning raises Whoop's blood pressure
BioWorld MedTech
The FDA’s warning letter to Whoop Inc. resurrects questions about the agency’s observance of the 21st Century Cures Act in that the warning letter stakes out the...